Machine-readable event card
- schema_version
- secwatch.filing_event.v1
- accession
- 0001437749-24-017365
- form_type
- 8-K
- ticker
- RBB
- cik
- 0001499422
- company_name
- RBB Bancorp
- filed_at
- 2024-05-17T23:59:59+00:00
- discovered_at
- 2026-05-14T18:03:18.686566+00:00
- generated_at
- 2026-06-01T15:22:26.008985+00:00
- sec_items
- ["5.02", "5.07", "8.01", "9.01"]
- event_type
- leadership
- sentiment
- neutral
- materiality_score
- 0.55
- calibrated_materiality_score
- 0.55
- confidence
- high
- secwatch_canonical_url
- https://secwatch.observer/filing/0001437749-24-017365
- json_url
- https://secwatch.observer/filing/0001437749-24-017365.json
- markdown_url
- https://secwatch.observer/filing/0001437749-24-017365.md
- text_url
- https://secwatch.observer/filing/0001437749-24-017365.txt
- edgar_index_url
- https://www.sec.gov/Archives/edgar/data/1499422/000143774924017365/0001437749-24-017365-index.htm
- edgar_primary_document_url
- https://www.sec.gov/Archives/edgar/data/1499422/000143774924017365/rbb20240514_8k.htm
- generated_by_model
- deepseek-v4-flash:cloud@v2
- review_status
- machine_generated
- human_reviewed
- false
- corrected
- false
- correction_note
- null
- correction_timestamp
- null
- superseded_by
- null
Source-grounded claims
a08711f02a
Dr. James Kao changed role as Director at RBB Bancorp.
Dr. James Kao, who has served as Chair of the Boards for the past three years, will remain on the Board of Directors of the Company and the Bank.
SEC 8-K Item 5.02
confidence 0.9
SEC evidence
f7c4139d62
Christina Kao was elected as Chair of the Board of Directors at RBB Bancorp.
Ms. Christina Kao was elected to serve as Chair of the Board of Directors.
SEC 8-K Item 5.02
confidence 0.95
SEC evidence
24061a99e6c352b8832dd967b945a23a34bf624b
RBB Bancorp shareholders approved Advisory vote to approve named executive officer compensation at the 2024-05-15 meeting.
FOR AGAINST ABSTAIN BROKER NON-VOTES 9,607,973 374,833 3,124 1,974,322
SEC 8-K Item 5.07
confidence 0.95
SEC evidence
613c9dbd7e9d19c79a064fcfeccd004d60aeb318
RBB Bancorp shareholders approved Ratification of Crowe LLP as independent auditor for fiscal year 2024 at the 2024-05-15 meeting.
FOR AGAINST ABSTAIN 11,908,859 50,343 1,050
SEC 8-K Item 5.07
confidence 0.95
SEC evidence
7785cc783d74c76beddbacf56954b65180f9a962
RBB Bancorp shareholders approved Advisory vote on frequency of say-on-pay votes (every year selected) at the 2024-05-15 meeting.
FOR 1 YEAR FOR 2 YEARS FOR 3 YEARS ABSTAIN 9,360,257 8,178 616,944 551
SEC 8-K Item 5.07
confidence 0.95
SEC evidence
d9ed7f80fbc83910bb2a4ca107282a3f16eec405
RBB Bancorp shareholders approved Election of ten nominees to the Board of Directors at the 2024-05-15 meeting.
For WITHHELD BROKER NON-VOTES William Bennett 9,959,621 26,309 1,974,322 Robert M. Franko 9,806,497 179,433 1,974,322 Dr. James W. Kao 9,925,987 59,943 1,974,322 Christina Kao 9,793,913 192,017 1,974,322 Joyce Wong Lee 9,928,586 57,344 1,974,322 Chuang-I (Christopher) Lin 9,672,110 313,820 1,974,322 Geraldine Pannu 9,809,098 176,832 1,974,322 Scott Polakoff 9,806,497 179,433 1,974,322 Frank Wong 9,959,624 26,306 1,974,322 David R. Morris 9,928,588 57,342 1,974,322
SEC 8-K Item 5.07
confidence 0.95
SEC evidence
Comparable filings
MGNO
Magnolia Bancorp names Robert Kimbro President/CEO; Hurley becomes Executive Chair
Magnolia Bancorp, Inc.
June 1, 2026, 2:15 PM ET
leadership
Items 5.02, 5.07, 7.01, 9.01
same fact type: executive_change, shareholder_vote
same SEC item: 5.02, 5.07, 9.01
same event type: leadership
similar materiality
This filing
Dr. James Kao, who has served as Chair of the Boards for the past three years, will remain on the Board of Directors of the Company and the Bank.
Comparable filing
On May 28, 2026, both the Company and the Association appointed Robert W. Kimbro as their President and Chief Executive Officer effective as of June 1, 2026.
Filing page
SEC filing
GPOR
Gulfport Energy appoints Domenic Dell'Osso to Board; CEO role effective May 28, 2026
GULFPORT ENERGY CORP
June 1, 2026, 4:10 PM ET
leadership
Items 5.02, 5.07
same fact type: executive_change, shareholder_vote
same SEC item: 5.02, 5.07
same event type: leadership
similar materiality
This filing
Dr. James Kao, who has served as Chair of the Boards for the past three years, will remain on the Board of Directors of the Company and the Bank.
Comparable filing
On May 28, 2026, the Board voted to increase the size of the Board to seven members and appointed Domenic J. Dell’Osso, Jr. to serve as a member of the Board until the 2027 Annual Meeting of Stockholders or until his successor is duly elected and qualified.
Filing page
SEC filing
GRAL
GRAIL appoints Joshua Ofman as CEO with amended compensation and severance
GRAIL, Inc.
June 1, 2026, 4:07 PM ET
leadership
Items 5.02, 8.01, 9.01
same fact type: executive_change
same SEC item: 5.02, 8.01, 9.01
same event type: leadership
similar materiality
This filing
Dr. James Kao, who has served as Chair of the Boards for the past three years, will remain on the Board of Directors of the Company and the Bank.
Comparable filing
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers In connection with Dr. Joshua Ofman’s appointment as the Chief Executive Officer of GRAIL, Inc. (the “Company”), on June 1, 2026, the Company’s board of directors (the “Board”) approved an amended and restated offer letter (the “Amended Offer Letter”) and authorized and directed the Company to enter into such Amended Offer Letter with Dr. Ofman, with the Amended Offer Letter effective as of June 1, 2026 (the “Effective Date”).
Filing page
SEC filing
BELFA
Bel Fuse names Kenneth Lai as SVP ITDS; annual meeting approves 2026 equity plan
BEL FUSE INC /NJ
May 28, 2026, 2:24 PM ET
leadership
Items 5.02, 5.07, 9.01
same fact type: executive_change
same SEC item: 5.02, 5.07, 9.01
same event type: leadership
similar materiality
This filing
Dr. James Kao, who has served as Chair of the Boards for the past three years, will remain on the Board of Directors of the Company and the Bank.
Comparable filing
on May 22, 2026, the Company determined to name Kenneth Lai as Senior Vice President ITDS, effective late second quarter or early third quarter of 2026. In this role, Mr. Lai’s responsibilities expand to include the Company’s India and private label operations, in addition to China and other Asia locations. As a result of this change in responsibilities, Mr. Lai is no longer determined to be an “executive officer” or “officer” of the Company as defined in Rules 3b-7 and 16a-1(f) under the Securities Exchange Act of 1934, as amended, respectively.
Filing page
SEC filing
ARQ
Arq appoints Shimon Steinmetz as CFO, CAO Stacia Hansen resigns
Arq, Inc.
May 27, 2026, 4:32 PM ET
leadership
Items 5.02, 8.01, 9.01
same fact type: executive_change
same SEC item: 5.02, 8.01, 9.01
same event type: leadership
similar materiality
This filing
Dr. James Kao, who has served as Chair of the Boards for the past three years, will remain on the Board of Directors of the Company and the Bank.
Comparable filing
On May 20, 2026, Stacia Hansen, the Chief Accounting Officer and Treasurer of the Company, submitted her resignation and the Board accepted such resignation. The effective date of Ms. Hansen's resignation as Chief Accounting Officer is expected to be June 12, 2026.
Filing page
SEC filing
ALNY
Alnylam elects Benjamin F. Cravatt to board; shareholders re-elect directors and approve say-on-pay
ALNYLAM PHARMACEUTICALS, INC.
May 27, 2026, 4:30 PM ET
leadership
Items 5.02, 5.07, 9.01
same fact type: executive_change
same SEC item: 5.02, 5.07, 9.01
same event type: leadership
similar materiality
This filing
Dr. James Kao, who has served as Chair of the Boards for the past three years, will remain on the Board of Directors of the Company and the Bank.
Comparable filing
Effective as of June 1, 2026, the Board of Directors (the “Board”) of Alnylam Pharmaceuticals, Inc. (the “Company”), following the recommendation of its Nominating and Corporate Governance Committee, expanded the size of the Company’s Board from ten to eleven and elected Benjamin F. Cravatt, Ph.D. to fill the newly created vacancy.
Filing page
SEC filing
CRVL
CorVel CEO Michael Combs to become Executive Chair; Sarah Scott appointed CEO and President effective July 1, 2026
CORVEL CORP
June 1, 2026, 5:05 PM ET
leadership
Items 5.02, 7.01, 9.01
same fact type: executive_change
same SEC item: 5.02, 9.01
same event type: leadership
similar materiality
This filing
Dr. James Kao, who has served as Chair of the Boards for the past three years, will remain on the Board of Directors of the Company and the Bank.
Comparable filing
In connection with the leadership transition, the Board appointed Sarah Scott to serve as Chief Executive Officer and President of the Company, effective July 1, 2026.
Filing page
SEC filing
WTTR
Select Water Solutions COO Skarke moves to Chief Commercial Officer; no successor named
Select Water Solutions, Inc.
June 1, 2026, 5:00 PM ET
leadership
Items 5.02, 9.01
same fact type: executive_change
same SEC item: 5.02, 9.01
same event type: leadership
similar materiality
This filing
Dr. James Kao, who has served as Chair of the Boards for the past three years, will remain on the Board of Directors of the Company and the Bank.
Comparable filing
Effective June 1, 2026, Michael C. Skarke transitioned from serving as the Executive Vice President and Chief Operating Officer of Select Water Solutions, Inc. (the “Company”) to serving as the Company’s Executive Vice President and Chief Commercial Officer,
Filing page
SEC filing
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.